-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L5+3DXPaQQnBynJnkQB0q8hFuA2oCFI6HpECUc8IYtVwpwX8OSdLcKTZve4OTROj 81QR2pUorGpMIp2y3nwlDw== 0000950162-03-001097.txt : 20030808 0000950162-03-001097.hdr.sgml : 20030808 20030808110518 ACCESSION NUMBER: 0000950162-03-001097 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030808 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 03830495 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 BUSINESS PHONE: 1264333455 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 8-K 1 shire8k080803.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2003 Shire Pharmaceuticals Group plc ________________________________________________________________________________ (Exact name of registrant as specified in its charter) England and Wales ________________________________________________________________________________ (State or other jurisdiction of incorporation) 0-29630 98-0359573 (Commission File Number) (IRS Employer Identification No.) Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP England ________________________________________________________________________________ (Address of principal executive offices) (Zip code) Registrant's telephone number, including area code 44 1256 894 000 ________________________________________________________________________________ (Former name or former address, if changed since last report) Item 5. Other Events Shire Pharmaceuticals Group plc has issued the press release attached as Exhibit 99.1 and incorporated by reference herein. Item 7. Financial Statements and Exhibits (c) Exhibits. The following exhibit is filed herewith: 99.1 Press Release dated August 8, 2003 -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 8, 2003 SHIRE PHARMACEUTICALS GROUP PLC By: /s/ Angus Russell ------------------------------- Name: Angus Russell Title: Group Finance Director EXHIBIT INDEX Number Description 99.1 Press Release dated August 8, 2003 EX-99.1 3 shire080803ex991.txt PRESS RELEASE Shire Pharmaceuticals Group plc Hampshire International Business Park, Chineham, Basingstoke RG24 8EP UK Tel +44 1256 894000 Fax +44 1256 894708 http://www.shire.com Shire SHIRE PHARMACEUTICALS GROUP PLC BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: ROBERTS PHARMACEUTICALS OPTION SCHEME 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 25,471,479 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 361,283 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 25,110,196 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 134,788,867 AND THE DATE OF ADMISSION: 22 DECEMBER 1999 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: STOCK PURCHASE PLAN 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 59,574 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 59,574 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 1,011,958 AND THE DATE OF ADMISSION: 2 APRIL 1996 (A FURTHER LISTING OF 513,488 SHARES WAS GRANTED ON 19 APRIL 2002) (A FURTHER LISTING OF 100,000 SHARES WAS GRANTED ON 12 JUNE 2002) PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: "B" EXECUTIVE SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 2,249,283 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 20,000 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 2,229,283 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 1,750,000 AND THE DATE OF ADMISSION: 12 MARCH 1999 (A FURTHER LISTING OF 3,250,000 SHARES WAS GRANTED IN AUGUST 2001) PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: "A" EXECUTIVE SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 183,066 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 13,761 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 169,305 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 250,000 AND THE DATE OF ADMISSION: 12 MARCH 1999 (A FURTHER LISTING OF 200,000 SHARES WAS GRANTED ON 19 APRIL 2002) PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE PHARMACEUTICALS SHARESAVE SCHEME 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 60,311 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 11,603 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 48,708 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 247,500 AND THE DATE OF ADMISSION: 21 AUGUST 1999 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE RICHWOOD INC SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 388,852 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 388,852 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 1,597,816 AND THE DATE OF ADMISSION: 31 MARCH 1999 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE LABORATORIES INC SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 36,592 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 36,592 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 1,741,654 AND THE DATE OF ADMISSION: 18 MARCH 1998 (A FURTHER LISTING OF 390,226 SHARES WAS GRANTED ON 31 MARCH 1999) PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE HOLDINGS LTD SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 3,040 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 3,040 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 1,011,958 AND THE DATE OF ADMISSION: 31 MARCH 1999 (A FURTHER LISTING OF 318,912 SHARES WAS GRANTED ON 19 APRIL 2002) PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE BIOCHEM STOCK OPTION PLAN 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 5,413,561 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 31,859 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 5,381,702 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 14,822,713 AND THE DATE OF ADMISSION: AUGUST 2001 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 BLOCK LISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: TPC WARRANTS 3. PERIOD OF RETURN: FROM: 1 JANUARY 2003 TO: 30 JUNE 2003 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 1,346,407 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 1,346,407 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED: 741,812 AND THE DATE OF ADMISSION: 29 APRIL 2002 (A FURTHER LISTING OF 604,595 SHARES WAS GRANTED ON 27 NOVEMBER 2002) PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 477,292,140 For further information please contact: Mark Prudden - Deputy Company Secretary +44 1256 894 276 Notes to editors Shire Pharmaceuticals Group plc Shire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently has a range of projects and products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal. Shire has operations in the world's key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug delivery unit in the US. For further information on Shire, please visit the Company's website: www.shire.com -----END PRIVACY-ENHANCED MESSAGE-----